Goldman Sachs Small Cap Equity Insights Fund BPMC Holdings History
Goldman Sachs Small Cap Equity Insights Fund's Blueprint Medicines Corp Holding Summary
As of 2025-04-30, GOLDMAN SACHS TRUST held 33,616.00 shares of Blueprint Medicines Corp(BPMC), totaling $3.01 Mil. This investment constitutes 0.78% of their stock portfolio, and GOLDMAN SACHS TRUST now holds 0.05% of the outstanding Blueprint Medicines Corp(BPMC) stock.
The initial trade took place in 2019Q4. And since then Goldman Sachs Small Cap Equity Insights Fund has made 6 purchases of BPMC, at an average price of $82.15, for a total of 95,632.00 shares. In addition, there have been 5 sales at an average price of $80.72 for 62,016.00 shares. Based on historical transaction data and BPMC's current price of $129.46, Goldman Sachs Small Cap Equity Insights Fund's estimated gain on his BPMC holdings is $1.50 Mil, reflecting a 19.11% gain to date.
Goldman Sachs Small Cap Equity Insights Fund BPMC ($129.46) Holding Chart
Goldman Sachs Small Cap Equity Insights Fund BPMC ($129.46) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1